Resources › EU Financial Regulatory Q&A Database EU Financial Regulatory Q&A Database Official Q&As published by EBA, ESMA, EIOPA and the ESA Joint Committee. Non-binding but treated
as authoritative guidance by national competent authorities across the EU.
Final — published answer Archive — superseded (EBA only) Pending — awaiting answer Rejected — out of scope or duplicate
All regulations Alternative Investment Fund Managers Directive (AIFMD) Directive 2011/61/EU Benchmarks Regulation (BMR) - Regulation 2016/1011 Central Securities Depositories Regulation (CSDR) Regulation (EU) No 909/2014- PTR- CSDR Credit Rating Agencies Regulation (CRAR) Regulation (EC) No 1060/2009 Directive 2002/87/EC (FiCOD) Directive 2009/110/EC (EMD) Directive 2013/36/EU (CRD) Directive 2014/17/EU (MCD) Directive 2014/49/EU (DGSD) Directive 2014/59/EU (BRRD) Directive 2014/65/EU - Markets in Financial Instruments Directive (MiFID II) Directive 2014/92/EU (PAD) Directive 2015/2366/EU (PSD2) Directive 2022/2556/EU (DORA Dir) Directive (EU) 2015/849 (AMLD) Directive (EU) 2019/2034 (IFD) EIOPA-BoS/18-114 - Information request towards NCAs regarding provision of occupational pensions information EIOPA-BoS-23-030 - Regular information requests regarding provision of occupational pensions information EMIR ESGR - Regulation (EU) 2024/3005 (EU) 2016/2341 - IORP II Directive (EU) 2016/2341 - IORP II Directive, (EU) No 2016/97 - Insurance Distribution Directive (EU) 2016/2341 - IORP II Directive, Other (EU) 2017/653 - PRIIPs Delegated Regulation for key information document (EU) 2017/653 - PRIIPs Delegated Regulation for key information document, (EU) No 1286/2014 - PRIIPs Regulation (EU) 2019/1238 - Pan-European Personal Pension Product (PEPP) (EU) 2019/1238 - Pan-European Personal Pension Product (PEPP), (EU) 2022/2454 - ITS with regard to supervisory reporting of risk concentrations and intra-group transactions (FICOD, (EU) 2023/894 - ITS with regard to the templates for the submission of information necessary for supervision, EIOPA-BoS-23-030 - Regular information requests regarding provision of occupational pensions information (EU) 2019/2088 - SFDR (EU) 2020/852 - Taxonomy Regulation (EU) 2022/2454 - ITS with regard to supervisory reporting of risk concentrations and intra-group transactions (FICOD (EU) 2022/2454 - ITS with regard to supervisory reporting of risk concentrations and intra-group transactions (FICOD, (EU) 2023/894 - ITS with regard to the templates for the submission of information necessary for supervision (EU) 2022/2554 - Digital Operational Resilience Act (DORA) (EU) 2023/894 - ITS with regard to the templates for the submission of information necessary for supervision (EU) 2023/894 - ITS with regard to the templates for the submission of information necessary for supervision, (EU) 2023/895 - ITS for the disclosure of solvency and financial condition report (EU) 2023/894 - ITS with regard to the templates for the submission of information necessary for supervision, (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII) (EU) 2023/894 - ITS with regard to the templates for the submission of information necessary for supervision, Other (EU) 2023/894 - ITS with regard to the templates for the submission of information necessary for supervision, Revised Guidelines on Contract Boundaries, Guidelines on contract boundaries (EU) 2023/895 - ITS for the disclosure of solvency and financial condition report EU Green Bond Regulation (EU) 2023/2361 (EU) No 1286/2014 - PRIIPs Regulation (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) (EU) No 2015/2011 - lists of regional governments & local authorities, exposures to be treated as to central government (EU) No 2015/2013 - standard deviations in relation to health risk equalisation systems (EU) No 2015/2450 - templates for the submission of information to the supervisory authorities (EU) No 2015/2450 - templates for the submission of information to the supervisory authorities, (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) (EU) No 2015/2450 - templates for the submission of information to the supervisory authorities, Guidelines on reporting and public disclosure (EU) No 2015/2451 - templates and structure of the disclosure of specific information by supervisory authorities (EU) No 2015/2451 - templates and structure of the disclosure of specific information by supervisory authorities, (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) (EU) No 2015/2452 - procedures, formats and templates of the solvency and financial condition report (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII) (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), (EU) No 2015/2011 - lists of regional governments & local authorities, exposures to be treated as to central government (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), (EU) No 2015/2450 - templates for the submission of information to the supervisory authorities (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), (EU) No 2015/2450 - templates for the submission of information to the supervisory authorities, (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Guidelines on application of outwards reinsurance (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Guidelines on contract boundaries (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Guidelines on group solvency (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Guidelines on implementation of the long-term guarantee measures (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Guidelines on look-through approach (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Guidelines on methodology for equivalence assessments by national supervisory authorities under Solvency II (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Guidelines on recognition and valuation of assets and liabilities other than technical provisions (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Guidelines on valuation of technical provisions (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Guidelines on valuation of technical provisions, (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Other (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Risk-Free Interest Rate - General questions (EU) No 2016/1800 - allocation of Credit Assessments of external CA institutions to objective scale of credit quality steps (EU) No 2016/97 - Insurance Distribution Directive (EU) No 2016/97 - Insurance Distribution Directive, (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) (EU) No 2017/1469 - standardised presentation format for the insurance product information document (EU) No 2017/1469 - standardised presentation format for the insurance product information document, Guidelines on classification of own funds (EU) No 2017/2358 - product oversight and governance requirements for insurance (EU) No 2017/2358 - product oversight and governance requirements for insurance, (EU) No 2016/97 - Insurance Distribution Directive (EU) No 2017/2358 - product oversight and governance requirements for insurance, Preparatory Guidelines on product oversight & governance arrangements by insurance undertakings & insurance distributors, (EU) No 2016/97 - Insurance Distribution Directive (EU) No 2017/2359 - info requirements and conduct of business rules applicable European Long-Term Investment Funds Regulation (ELTIF) Regulation (EU) 2015/760 European Market Infrastructure Regulation (EMIR) Regulation (EU) No 648/2012- MDP European Market Infrastructure Regulation (EMIR) Regulation (EU) No 648/2012- PTR- Derivatives European Social Entrepreneurship Funds Regulation (EuSEF) Regulation (EU) No 346/2013 European Venture Capital Regulation (EuVECA) Regulation (EU) No 345/2013 Guidelines on application of life underwriting risk module Guidelines on application of outwards reinsurance Guidelines on basis risk Guidelines on classification of own funds Guidelines on classification of own funds, (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) Guidelines on contract boundaries Guidelines on financial stability reporting Guidelines on financial stability reporting, Guidelines on reporting for financial stability purposes Guidelines on group solvency Guidelines on health catastrophe risk sub-module Guidelines on look-through approach Guidelines on loss-absorbing capacity of technical provisions and deferred taxes Guidelines on own risk and solvency assessment Guidelines on recognition and valuation of assets and liabilities other than technical provisions Guidelines on reporting and public disclosure Guidelines on reporting for financial stability purposes Guidelines on ring-fenced funds Guidelines on submission of information to NCAs (Preparatory phase) Guidelines on supervision of branches of third-country insurance undertakings Guidelines on supervisory review process Guidelines on system of governance Guidelines on the Forward looking assessment of own risks Guidelines on treatment of related undertakings, including participations Guidelines on use of internal models Guidelines on valuation of technical provisions Market Abuse Regulation (MAR) Regulation (EU) No 596/2014 - Market Intergrity Markets in Financial Instruments Directive II (MiFID II) Directive 2014/65/EU- Investor Protection and Intermediaries Markets in Financial Instruments Directive II (MiFID II) Directive 2014/65/EU- MDP Markets in Financial Instruments Directive II (MiFID II) Directive 2014/65/EU- Secondary Markets Markets in Financial Instruments Regulation (MiFIR) Regulation (EU) No 600/2014 - Investor Protection and Intermediaries Markets in Financial Instruments Regulation (MiFIR) Regulation (EU) No 600/2014- MDP Markets in Financial Instruments Regulation (MiFIR) Regulation (EU) No 600/2014- Secondary Markets MiCA Other Packaged Retail and Insurance-based Investment Products Regulation (PRIIPS) Regulation (EU) No 1286/2014 PRIIPs Prospectus Regulation 2017/1129 Regulation 2020/1503 - European crowdfunding service providers for business Regulation 2021/23 - recovery and resolution of central counterparties (CCPRRR) Regulation 648/2012 - OTC derivatives, central counterparties and trade repositories (EMIR) - CCPs Regulation (EU) 2015/847 (WTR) (recast) Regulation (EU) 2019/2088 - Sustainable Finance Disclosure Regulation (SFDR) Regulation (EU) 2022/2554 - The Digital Operational Resilience Act (DORA) Regulation (EU) 2022/858 - DLT Pilot Regime Regulation (DLTR) Regulation (EU) 2023/1113 (WTR II) Regulation (EU) 2024/886 (IPR) Regulation (EU) No 2017/2402 (SecReg) Regulation (EU) No 2019/2033 (IFR) Regulation (EU) No 2022/2554 (DORA Reg) Regulation (EU) No 2023/1114 (MiCAR) Regulation (EU) No 575/2013 (CRR) Regulation (EU) No 648/2012 (EMIR) Regulation (EU) No 909/2014 (CSDR) - only RTS 2017/390 Revised Guidelines on Contract Boundaries Revised Guidelines on valuation of technical provisions Revised Guidelines on valuation of technical provisions, (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII) Revised Guidelines on valuation of technical provisions, (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) Risk-Free Interest Rate - Credit and currency adjustments Risk-Free Interest Rate - Deep, Liquid and Transparent maturities Risk-Free Interest Rate - Extrapolation Risk-Free Interest Rate - Extrapolation, Risk-Free Interest Rate - Financial market data Risk-Free Interest Rate - Extrapolation, Risk-Free Interest Rate - General questions, Risk-Free Interest Rate - VA calculations Risk-Free Interest Rate - Financial market data Risk-Free Interest Rate - General questions Risk-Free Interest Rate - Matching adjustment Risk-Free Interest Rate - Matching adjustment, (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) Risk-Free Interest Rate - VA calculations Risk-Free Interest Rate - VA calculations, Risk-Free Interest Rate - VA representative portfolios Risk-Free Interest Rate - VA representative portfolios Securities Financing Transactions Regulation (SFTR) Regulation (EU) 2015/2365- MDP Securitisation Regulation (EU) 2017/2402 SFDR Short Selling Regulation (SSR) Regulation (EU) No 236/2012 Symmetric adjustment of the equity capital charge Transparency Directive (TD) Directive 2004/109/EC Undertakings for Collective Investment in Transferable Securities Directive (UCITS) Directive 2009/65/EC
7,005 Q&As · page 111 of 141
Some fees are paid from the fund/investors to the manager based on the narrowing of the share price
to NAV discount on a closed-ended listed fund. Should this type of fee be classed as a performance
f
PRIIPs
Joint Committee Final
Answered 2017-07-04
In the case of private Equity, infrastructure and other similar funds where the investments to be made
by those funds are unknown at the date of creation/investment in the fund, how to anticipate cost
PRIIPs
Joint Committee Final
Answered 2017-07-04
Point 80 of Annex VI specifies that “the costs are assessed on an ‘all taxes included’ basis. Which types
of taxes are referred to in this point?
PRIIPs
Joint Committee Final
Answered 2017-07-04
At what frequency must the Recurring costs and Incidental costs be calculated?
PRIIPs
Joint Committee Final
Answered 2017-07-04
Could you provide an example of the provisioned fees for specific treatment of gain and losses, which
are referred to in Point 5 (d) of Annex VI?
PRIIPs
Joint Committee Final
Answered 2017-07-04
Should entry and exit costs under the table ‘Composition of costs’ of Annex VII be recalculated as an
impact per year based on the recommended holding period instead of a RIY figure?
No, the calculati
PRIIPs
Joint Committee Final
Answered 2017-07-04
For new funds with performance fees, is it possible to refer to an appropriate benchmark for
estimating the relevant returns of a peer group as foreseen in Point 24(b)(ii) second subparagraph of
Annex
PRIIPs
Joint Committee Final
Answered 2017-07-04
Are portfolio costs for traditional endowment insurances to be taken into account in the summary
cost indicator of the KID?
PRIIPs
Joint Committee Final
Answered 2017-07-04
According to the Point 37 of Annex VI ‘If the PRIIP manufacturer is unable to distinguish the relevant
implicit costs to be disclosed as referred to in Point 29 of this Annex using the difference betw
PRIIPs
Joint Committee Final
Answered 2017-07-04
What value should be input into portfolio transaction costs of PRIPs other than investment funds?
PRIIPs
Joint Committee Final
Answered 2017-07-04
Is it correct to say that for the purpose of the Points 36 and the following provisions, while the fair
value of the product needs to be in line with accounting standards, it does not have to be neces
PRIIPs
Joint Committee Final
Answered 2017-07-04
What could be the ‘reference indexes’ mentioned in Point 21(c)(i) of the Annex VI of the Commission
Delegated Regulation?
PRIIPs
Joint Committee Final
Answered 2017-07-04
According to Point 33 (b) of Annex VI, the costs of the underlying shall be taken into account in the
list of costs of PRIPs other than investment funds. How should this requirement be understood in t
PRIIPs
Joint Committee Final
Answered 2017-07-04
Should transaction costs be calculated the same way in the ‘Composition of costs’ and the ‘Cost over
time’ table?
Yes, in both cases, transaction costs should be calculated according to Point 66 and t
PRIIPs
Joint Committee Final
Answered 2017-07-04
According to Point 21 of the Annex VI of the Commission Delegated Regulation for PRIIPs that have
been operating less than 3 years transaction costs may be calculated as an average of the actual
trans
PRIIPs
Joint Committee Final
Answered 2017-07-04
- Guidance on the methodology described in Point 21(c)(ii) to estimate transaction costs:
3. What could be the ‘comparable information’ mentioned in Point 21 (c) (ii) of the Annex VI of the
Commission
PRIIPs
Joint Committee Final
Answered 2017-07-04
Are we right to assume that the bootstrapping of equity baskets should also be based on a principal
component decomposition (at least for baskets of more than two underlyings)? On which rule should
th
PRIIPs
Joint Committee Final
Answered 2017-07-04
Could you provide an example of the ‘dividends served by the shares held in the portfolio of the
funds, shall the dividends not accrue to the fund’ mentioned in Point 5 (r) of Annex VI?
PRIIPs
Joint Committee Final
Answered 2017-07-04
The principal component analysis of Annex II, Point 23 ensures the consistent simulation of curves. Is
it mandatory to use this method also for PRIIPs that depend on only one interest rate underlying,
PRIIPs
Joint Committee Final
Answered 2017-07-04
For PRIIPs that allow for investment in underlying instruments of a different nature, which are
classified in different groups for risk calculation, how should the Summary Risk Indicator (SRI) be
calc
PRIIPs
Joint Committee Final
Answered 2017-07-04
For products with an automatic early-redemption feature, the holding periods might differ for each
of the simulations. What value of T, related to the formula for the calculation of the MRM, the lengt
PRIIPs
Joint Committee Final
Answered 2017-07-04
Does the formula in Annex II Point 17 use the simulated value of the PRIIP divided by its initial value?
Should the calculation of VEV post-issuance be based on the ratio of the simulated value divide
PRIIPs
Joint Committee Final
Answered 2017-07-04
The MRM class determination for Category 3 PRIIPs, as specified in Annex II, Point 16, states that the
“[…] VaR shall be the value of the PRIIP at the 97.5% confidence level […]”. Since the formula in
PRIIPs
Joint Committee Final
Answered 2017-07-04
If the recommended holding period (RHP) of the PRIIP is less than one year, how should performance
and cost figures be presented in the KID?
Point 45 of Annex IV and point 76a of Annex VI of the Deleg
PRIIPs
Joint Committee Final
Answered 2017-07-04
Is the provision in Annex II, Part 1, Point 14 (b) applicable where a fund has sufficient history?
PRIIPs
Joint Committee Final
Answered 2017-07-04
Could you specify which types of costs of capital guarantee provided by a third party guarantor are
those mentioned in Point 5 (i) of Annex VI?
PRIIPs
Joint Committee Final
Answered 2017-07-04
While financing costs related to borrowing (provided by related parties)” are recognised as a
recurring cost in Point 5(h) of Annex VI, could you confirm that overdraft charges on a bank account
opera
PRIIPs
Joint Committee Final
Answered 2017-07-04
What is the meaning of the term “underlying investments” in Annex II, Part 1, Points 4-6 for a PRIIP
that is an Undertaking for Collective Investment (UCI)? In particular, do we need to look at the
po
PRIIPs
Joint Committee Final
Answered 2017-07-04
Does Point 53 of Annex VI apply inter alia to insurance-based investment products (unit-linked
products as well as non-unit-linked products) in which the capital provided by investors is invested in
U
PRIIPs
Joint Committee Final
Answered 2017-07-04
Will it be possible for the manufacturer to include certain products, such as leveraged products,
voluntarily in “Category 1” for the purposes of the market risk assessment?
PRIIPs
Joint Committee Final
Answered 2017-07-04
It appears that unit-linked insurance products without guarantees would fall into Category 2.
PRIIPs
Joint Committee Final
Answered 2017-07-04
Clarification is necessary on the specific currency risks which will be covered by Element C of Annex
III of the Commission Delegated Regulation. Clarification is necessary for PRIIPs distributed
simu
PRIIPs
Joint Committee Final
Answered 2017-07-04
The main difference between Category 2 and Category 3 is whether the condition of “constant
multiple” is fulfilled in Annex II, Part 1, Point 5. Would it be correct to treat unit-linked insurance
prod
PRIIPs
Joint Committee Final
Answered 2017-07-04
Are PRIIPs with unconditional capital protection categorised as Category 2 or Category 3?
PRIIPs
Joint Committee Final
Answered 2017-07-04
Would a hedge fund that meets the following criteria be considered a Category 1 or Category 3 PRIIP?
PRIIPs
Joint Committee Final
Answered 2017-07-04
Independence of management boards and supervisory functions - Group links, independence and cooling-off periods
Undertakings for Collective Investment in Transferable Securities Directive (UCITS) Directive 2009/65/EC
ESMA Answer Published
Answered 2017-07-01
Speculative immovable property financing
Regulation (EU) No 575/2013 (CRR) · Art. 4, 128
EBA Final Q&A
Answered 2017-06-30
Use of bona fide estimates for the determination of the size of a corporation
Regulation (EU) No 575/2013 (CRR) · Art. 153, 162
EBA Final Q&A
Answered 2017-06-30
Systemic risk buffer requirement calculation
Directive 2013/36/EU (CRD) · Art. 133
EBA Final Q&A
Answered 2017-06-30
Contingent liabilities within the Merchant Services Industry
Regulation (EU) No 575/2013 (CRR) · Art. 99
EBA Final Q&A
Answered 2017-06-30
Short positions in financial institution capital instruments
Regulation (EU) No 575/2013 (CRR) · Art. 36, 45
EBA Final Q&A
Answered 2017-06-30
Written Credit Derivatives Add-On MR/NR Netting
Regulation (EU) No 575/2013 (CRR) · Art. 429d
EBA Final Q&A
Answered 2017-06-30
CVA Standardised Method for Securities Financing Transactions (SFTs)
Regulation (EU) No 575/2013 (CRR) · Art. 384
EBA Final Q&A
Answered 2017-06-30
Private ownership of a bridge institution or an asset management tool
Directive 2014/59/EU (BRRD) · Art. 40, 42
EBA Final Q&A
Answered 2017-06-23
O-SII buffer / Capital conservation buffer application
Directive 2013/36/EU (CRD) · Art. 131, 141a
EBA Final Q&A
Answered 2017-06-16
Calculation of the Countercyclical Capital Buffer
Directive 2013/36/EU (CRD) · Art. 140
EBA Final Q&A
Answered 2017-06-16
Reporting of assets lending on an unsecured basis
Regulation (EU) No 575/2013 (CRR) · Art. 425
EBA Final Q&A
Answered 2017-06-16
Information on cost and charges
Markets in Financial Instruments Directive II (MiFID II) Directive 2014/65/EU- Investor Protection and Intermediaries
ESMA Answer Published
Answered 2017-06-06
Information on cost and charges
Markets in Financial Instruments Directive II (MiFID II) Directive 2014/65/EU- Investor Protection and Intermediaries
ESMA Answer Published
Answered 2017-06-06
Information on cost and charges
Markets in Financial Instruments Directive II (MiFID II) Directive 2014/65/EU- Investor Protection and Intermediaries
ESMA Answer Published
Answered 2017-06-06
← Previous 1 109 110 111 112 113 141 Next → Source: EBA Single Rulebook Q&A , ESMA Q&A , EIOPA Q&A , ESA Joint Q&As . Updated weekly. Q&As are non-binding guidance.